Analysis of clinical characteristics and S gene mutation of hepatitis B virus (HBV) in patients with hepatitis B surface antigen RIA negative and HBV DNA positive;BSouth Korea (HBV) DNA Korean Source HBV South Korea BSouth Korea S Korean Source

Korean Journal of Laboratory Medicine

Volumn 29, Issue 3, 2009, Pages 224-230

  Sohn, Yong Hak ^a   Oh, Heung Bum ^a   Ko, Sun Young ^a   Lim, Young Suk ^b   Kwon, Oh Joong ^c  

^a Laboratory Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Seoul Medical Science Institute   (South Korea)

Author keywords

HBIG escape mutation; HBsAg assay; Hepatitis B virus; Occult hepatitis B virus infection

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B HYPERIMMUNE GLOBULIN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR; VIRUS DNA;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; FEMALE; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; RADIOIMMUNOASSAY; VIROLOGY;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULINS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; RADIOIMMUNOASSAY;

EID: 70349329269     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2009.29.3.224     Document Type: Article

References (23)

1. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007; 46: 160-70.
2. Carreno V, Bartolome J, Castillo I, Quiroga JA. Occult hepatitis B virus and hepatitis C virus infections. Rev Med Virol 2008; 18: 139-57.
3. Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 2008; 48: 1001-26.
4. Coleman PF, Chen YC, Mushahwar IK. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 1999; 59: 19-24.
5. La'ulu SL and Roberts WL. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays. Am J Clin Pathol 2006; 125: 748-51.
6. Cha CH, Sohn YH, Jang S, Lee HJ, Lee KJ, Shin ES, et al. Genotype analysis of hepatitis B virus isolated from Korean hepatitis patients. Korean J Lab Med 2003; 23: 352-6. (Korean Source BKorean Source 2003;23:352-6.)
7. Soldan K, Ramsay M, Collins M. Acute hepatitis B infection associated with blood transfusion in England and Wales, 1991-7: review of database. BMJ 1999; 318: 95.
8. Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, et al. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol 2006; 44: 39-46.
9. Saraswat S, Banerjee K, Chaudhury N, Mahant T, Khandekar P, Gupta RK, et al. Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol 1996; 25: 639-43.
10. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, et al. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007; 47: 1197-205.
11. Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 2005; 32: 102-12.
12. Carman WF, Trautwein C, van Deursen FJ, Colman K, Dornan E, McIntyre G, et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996; 24: 489-93.
13. Terrault NA, Zhou S, McCory RW, Pruett TL, Lake JR, Roberts JP, et al. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology 1998; 28: 555-61.
14. Cooreman MP, Leroux-Roels G, Paulij WP. Vaccine-and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 2001; 8: 237-47.
15. Zanetti AR, Tanzi E, Manzillo G, Maio G, Sbreglia C, Caporaso N, et al. Hepatitis B variant in Europe. Lancet 1988; 2: 1132-3.
16. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325-9.
17. Oon CJ, Chen WN, Goo KS, Goh KT. Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145-R. J Infect 2000; 41: 260-4.
18. Chakravarty R, Neogi M, Roychowdhury S, Panda CK. Presence of hepatitis B surface antigen mutant G145R DNA in the peripheral blood leukocytes of the family members of an asymptomatic carrier and evidence of its horizontal transmission. Virus Res 2002; 90: 133-41.
19. Song BC, Kim SH, Kim H, Ying YH, Kim HJ, Kim YJ, et al. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J Med Virol 2005; 76: 194-202.
20. Hsu CW, Yeh CT, Chang ML, Liaw YF. Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance. Gastroenterology 2007; 132: 543-50.
21. Lee SY, Choi MS, Lee D, Lee JH, Koh KC, Paik SW, et al. Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy. J Korean Med Sci 2005; 20: 433-7.
22. Bartholomeusz A and Locarnini S. Hepatitis B virus mutations associated with antiviral therapy. J Med Virol 2006; 78(S1): S52-5.
23. Huh HJ, Chae SL, Cha YJ. Comparison study with enzyme immunoassay and chemiluminescence immunoassay for hepatitis B virus surface antigen detection. Korean J Lab Med 2007; 27: 355-9. (Korean Source BKorean Source 2007;27:355-9.)